MacroChem Corporation Report issue

For profit Phase 2 Phase 3
Founded: Wellesley Hills MA United States (1981)
Status: Acquired by Access Pharmaceuticals, Inc. (2008) → now Abeona Therapeutics (2014)

Organization Overview

First Clinical Trial
1994
NCT00563394
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

ofloxacin (floxin) (2 trials)

pexiganan acetate (2 trials)

Drugs in Phase 2 Trials (1)

econazole (spectazole) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Onychomycosis (Phase 2)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3